VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | -99.6% | 56 | -99.5% | 0.00% | -100.0% |
| Q4 2017 | $224,000 | +366.7% | 10,768 | +222.0% | 0.02% | +300.0% |
| Q3 2017 | $48,000 | -4.0% | 3,344 | +15.8% | 0.01% | -28.6% |
| Q2 2017 | $50,000 | -32.4% | 2,887 | -57.2% | 0.01% | -36.4% |
| Q1 2017 | $74,000 | +572.7% | 6,746 | +1347.6% | 0.01% | +450.0% |
| Q3 2016 | $11,000 | +266.7% | 466 | +180.7% | 0.00% | +100.0% |
| Q2 2016 | $3,000 | -25.0% | 166 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | -63.6% | 166 | +50.9% | 0.00% | -75.0% |
| Q4 2015 | $11,000 | -87.6% | 110 | -77.9% | 0.00% | -85.2% |
| Q3 2015 | $89,000 | -85.3% | 498 | -81.2% | 0.03% | -84.8% |
| Q2 2015 | $604,000 | +8.6% | 2,647 | -5.8% | 0.18% | +15.6% |
| Q1 2015 | $556,000 | +12.1% | 2,809 | -11.6% | 0.15% | -0.6% |
| Q4 2014 | $496,000 | +118.5% | 3,177 | +76.2% | 0.16% | +61.5% |
| Q2 2014 | $227,000 | +8.6% | 1,803 | +13.8% | 0.10% | -11.1% |
| Q1 2014 | $209,000 | +945.0% | 1,584 | +842.9% | 0.11% | +980.0% |
| Q4 2013 | $20,000 | – | 168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |